CAMP4 Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CAMP and other ETFs, options, and stocks.

About CAMP

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. 

CEO
Josh Mandel-Brehm
CEOJosh Mandel-Brehm
Employees
55
Employees55
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2015
Founded2015
Employees
55
Employees55

CAMP Key Statistics

Market cap
245.40M
Market cap245.40M
Price-Earnings ratio
-1.90
Price-Earnings ratio-1.90
Dividend yield
Dividend yield
Average volume
111.54K
Average volume111.54K
High today
High today
Low today
Low today
Open price
$4.64
Open price$4.64
Volume
0.00
Volume0.00
52 Week high
$7.31
52 Week high$7.31
52 Week low
$1.31
52 Week low$1.31

Stock Snapshot

With a market cap of 245.4M, CAMP4 Therapeutics(CAMP) trades at $4.67. The stock has a price-to-earnings ratio of -1.90.

During the trading day, CAMP4 Therapeutics(CAMP) stock saw an opening price of $4.64, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 111.54K.

Over the past 52 weeks, CAMP4 Therapeutics(CAMP) stock has traded between a high of $7.31 and a low of $1.31.

Over the past 52 weeks, CAMP4 Therapeutics(CAMP) stock has traded between a high of $7.31 and a low of $1.31.

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

People also own

Based on the portfolios of people who own CAMP. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.